Search publications

Publications

  • Ottenhoff MJ, Mous SE, Castricum J, Rietman AB, Oostenbrink R, van der Vaart T, Tulen JHM, Parra-Checa A, Ramos F, Legius E, Moll HA, Elgersma Y and de Wit MY.

    Lamotrigine for cognitive deficits associated with neurofibromatosis type 1: A phase II randomized placebo-controlled trial.

    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY . : .

    [doi:10.1111/dmcn.16094]